Kyverna Therapeutics, Inc. KYTX Business Segments
| FY'25 | FY'24 | ||
|---|---|---|---|
| External Research And Development Expenses Allocated By Program by Product | |||
| KYV One Zero One | $76.05M+22.9% | $61.88M+239% | |
| Other Program | $3.29M-16.6% | $3.95M-12.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Kyverna Therapeutics, Inc. break its business down?
- Kyverna Therapeutics, Inc. (KYTX) reports external research and development expenses allocated by program by product across 2 parts — KYV One Zero One and Other Program. Each is extracted from the segment footnotes and tracked over time.
- Where does Kyverna Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Kyverna Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.